Peptide merchant accounts and high-risk research-compound payment processing.
Research-compound suppliers sit in one of the narrowest acquiring niches: legal to sell in many markets, but treated by most processors as pharmaceuticals. KLAUDE works with partners that accept compliant research-use suppliers and helps structure product presentation, labelling and marketing so applications are not declined on sight.
What makes payments difficult in this category
- Near-universal exclusion by mainstream processors
- Product legality and labelling that differ by market
- Marketing claims that trigger pharmaceutical classification
- Acquirer caps and reserves driven by category risk
How KLAUDE approaches it
- Acquirers with defined programmes for research-use suppliers
- Product, labelling and marketing review before submission
- Bank transfer and alternative methods alongside cards
- Chargeback alerts and prevention
Eligibility and compliance
Products must be lawful to sell in each market, labelled and marketed strictly for their lawful use, with no medical or human-consumption claims. Controlled or prescription-only substances are not supported.
KLAUDE does not assist any business in evading banking rules, sanctions, KYC/AML obligations, card-network requirements or regulation. Final acceptance is determined by acquiring-partner underwriting.
Not sure your peptides & research compounds site will pass underwriting?
Send us the URL. A payment specialist checks it against the thirteen points acquirers look at and tells you what to fix before you apply. Free, confidential, two business days.
Relevant products
All productsCard acquiring
Visa, Mastercard and local card schemes through acquiring relationships matched to your business model and markets.
Learn moreAlternative payment methods
Wallets, bank transfers, open banking, instalments and local methods that lift conversion in each market.
Learn moreChargeback management
Prevent disputes before they happen and manage the ones that do — keeping ratios inside scheme thresholds.
Learn moreCommon questions
Does KLAUDE support high-risk merchants?
Yes. Many of the businesses we work with would be labelled "high risk" by mainstream processors. We prefer to think in terms of complex requirements rather than risk labels, but the practical answer is that we arrange acquiring for categories most providers decline — provided the business is lawful, licensed where required and willing to meet acquirer standards.
How long does merchant onboarding take?
Our initial review typically takes a few business days. Acquirer underwriting then ranges from under a week for straightforward profiles to several weeks for complex or licensed categories. The largest factor is how complete your documentation is — we give you a checklist up front so nothing is missing.
Can KLAUDE provide multiple merchant accounts?
Where it makes sense, yes. Multiple MIDs across different acquirers give you redundancy and allow volume to be spread. Note that card-scheme rules prohibit using multiple accounts to disguise volume or evade monitoring programmes; we only structure multi-acquirer setups for legitimate resilience and optimisation purposes.
Can KLAUDE help with international payment processing?
Yes. We arrange local acquiring and local payment methods in Europe, the UK, North America, LATAM and APAC where your business profile qualifies. Some markets require a local entity or licence; we explain those requirements before you commit.
Which currencies are supported?
Presentment in 100+ currencies and settlement in major currencies including EUR, GBP and USD are available depending on the acquiring partner. Exact currency support is confirmed during placement.